Français    English                     
Prof. Roland Asmar
Cardiology & vascular Diseases

 
Home Biography & CV Education & career overview Titles & Functions
Distinction & Awards Healthcare & Research Teaching & Editorial Humanitarian & associations activities Publication Media & Events Contact
 

    
    
Publication Scientific Articles

2001 - 2010
O'Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, Imai Y, Wang J, Mengden T, Shennan A;
Working Group on Blood Pressure Monitoring of the European Society of Hypertension. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults.
Blood Press Monit 2010;15(1):23-38.

Asmar R, Belghazi J, Khabouth J, Mattar J, Psimenos A, Germano G.
Validation of three professional devices measuring office blood pressure according to three different methods: the Omron BP10, the Omron HBP T105 and the Pic Indolor Professional.
J Hypertens 2010; 28(3): 452-458.

Asmar R, El Feghali R, Rejdych M,
for the French Investigator Group. Antihypertensive effect of candesartan versus ramipril using ambulatory blood pressure monitoring in hypertensive patients. The Carapas study.
Blood Press J 2010 (in press)

Cremer A, Coulon P, Codjo L, Litalien J, Lemetayer Ph, Coste P, Asmar R,Gosse Ph.
Determination of central blood pressure by a non-invasive method (brachial BP and QKD interval.
(submitted)

Codjo L, Coulon P, Cremer A, Litalien J, Lemetayer Ph, Coste P, Asmar R,Gosse Ph.
Estimation of centralblood pressure from the QKD interval. Validation by a non-invasive method.
(submitted)

Asmar R, Gosse P, Queré S, Achouba A.
Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by amlodipine 5 mg.
(submitted)

Asmar R, Topouchian J, El Feghali R, Pannier B, Koon T, Gao P,
on behalf of the TRANS investigators. Arterial stiffness in patients at high cardiovascular risk - the TRanscend arterial stiffNess Substudy (TRANS study).
(submitted)

Asmar R, Khabouth J, Topouchian J, El Feghali R, Mattar J.
Validation of three automatic devices for self-measurement of blood pressure according to the International Protocol: The Omron M3 Intellisense (HEM-7051-E), the Omron M2 Compact (HEM 7102-E), and the Omron R3-I Plus (HEM 6022-E).
Blood Press Monit 2010;15(1):49-54.

Germano G, Psimenos A, Sarullo F, Venditti A, Pecchioli V, Asmar R.
Validation of four automatic devices for self-measurement of blood pressure according to the International Protocol: the Pic Indolor Personal Check, Comfort Check, My Check and Travel Check.
Blood Press Suppl 2009;1:15-23.

Postel-Vinay N, Bobrie G, Asmar R.
[Patient reporting of self-measurement results: survey Autoprov].
Rev Prat 2009;59(8 Suppl):8-12.

Sie MP, Yazdanpanah M, Mattace-Raso FU, Uitterlinden AG, Hofman A, Hoeks AP, Reneman RS, Asmar R, Van Duijn CM, Witteman JC.
Genetic variation in the renin-angiotensin system and arterial stiffness. The Rotterdam Study
Clin Exp Hypertens 2009;31(5):389-99.

Halimi JM, Asmar R, Ribstein J.
Optimal nephroprotection: use, misuse and misconceptions about blockade of the renin-angiotensin system
Lessons from the ONTARGET and other recent trials. Diabetes Metab 2009;35(6):425-30.

Asmar R, Hosseini H.
Endpoints in clinical trials: does evidence only originate from 'hard' or mortality endpoints?
J Hypertens 2009;27 Suppl 2:S45-50.

Baguet JP, Asmar R, Valensi P, Nisse-Durgeat S, Mallion JM.
Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study.
Vasc Health Risk Manag 2009;5(1):175-83.

Sie MP, Mattace-Raso FU, Uitterlinden AG, Arp PP, Hofman A, Pols HA, Hoeks AP, Reneman RS, Asmar R, van Duijn CM, Witteman JC.
The interleukin-6-174 G/C promoter polymorphism and arterial stiffness; the Rotterdam Study.
Vasc Health Risk Manag 2008;4(4):863-9.

Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P.
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Lancet 2008;372(9644):1174-83.

Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T, O'Brien E, Ohkubo T, Padfield P, Palatini P, Pickering T, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Waeber B, Zanchetti A, Mancia G;
ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring
J Hypertens 2008;26(8):1505-26.

Faergeman O, Hill L, Windler E, Wiklund O, Asmar R, Duffield E, Sosef F;
ECLIPSE Study Investigators. Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study.
Cardiology 2008;111(4):219-28.

Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C,
ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events
N Engl J Med 2008;358(15):1547-59.

Belghazi J, El Feghali RN, Moussalem T, Rejdych M, Asmar RG.
Validation of four automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension.
Vasc Health Risk Manag 2007;3(4):389-400.

Asmar R, Achouba Assya, Brunel P, El Feghali R, Denolle T, Vaisse B
A specific training on hypertension guidelines improves blood pressure control by more than 10% in hypertensive patients : the VALNORM study.
J Am Society Hypertens 2007;1(4): 278-285.

Topouchian J, El Feghali R, Pannier B, Wang S, Zhao F, Smetana K, Teo K, Asmar R
Arterial stiffness and pharmacological interventions--the TRanscend arterial stiffNess Substudy (TRANS study).
Vasc Health Risk Manag 2007;3(4):381-7.

Asmar R, Garcia-Puig J, Gosse P, Karpov YA, De Leeuws PW, Magometschniggs D, Matos L, Schmieder R.
Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy
Vasc Health Risk Manag. 2007;3(4):371-80.

El Féghali R, Nisse-Durgeat S, Asmar R.
Efficacy of candesartan cilexetil in hypertensive patients with or without diabetes.
Arch Mal Coeur Vaiss 2007;100(8):679-82.

Asmar R.
Blood pressure. Regulation and epidemiology. Standard measures and values.
Nephrol Ther 2007;3(4):163-84.

Valensi P, Baguet JP, Asmar R, Nisse Durgeat S, Mallion JM.
Effect of Candesartan Cilexetil on Carotid Intima-Media Thickness in hypertensive type 2 diabetic patients. MITEC Study: Design and baseline characteristics
Br J Diabetes Vasc Dis 2007;7:18-24.

Féghali RE, Nisse-Durgeat S, Asmar R.
Effect of candesartan cilexetil on diabetic and non-diabetic hypertensive patients: meta-analysis of five randomized double-blind clinical trials
Vasc Health Risk Manag 2007;3(1):165-71.

Zoungas S, Asmar R.
Arterial stiffness and cardiovascular outcome.
Clin Exp Pharmacol Physiol 2007;34(7):647-51.

Asmar R.
Fixed-dose combination lercanidipine/enalapril: a viewpoint by Roland Asmar.
Drugs 2007;67(1):107-108.

El Feghali RN, Topouchian JA, Pannier BM, El Assaad HA, Asmar RG; European Society of Hypertension
Validation of the OMRON M7 (HEM-780-E) blood pressure measuring device in a population requiring large cuff use according to the International Protocol of the European Society of Hypertension.
Blood Press Monit 2007;12(3):173-8.

Sie MP, Mattace-Raso FU, Uitterlinden AG, Arp PP, Hofman A, Hoeks AP, Reneman RS, Asmar R, van Duijn CM, Witteman JC.
TGF-beta1 polymorphisms and arterial stiffness; the Rotterdam Study
J Hum Hypertens 2007;21(6):431-7.

El Feghali R, Topouchian J, Pannier B, Asmar R.
Ageing and blood pressure modulate the relationship between metabolic syndrome and aortic stiffness in never-treated essential hypertensive patients. A comparative study
Diabetes Metab 2007;33(3):183-8.

Puig JG, Marre M, Kokot F, Fernandez M, Jermendy G, Opie L, Moyseev V, Scheen A, Ionescu-Tirgoviste C, Saldanha MH, Halabe A, Williams B, Mion D Jr, Ruiz M, Hermansen K, Tuomilehto J, Finizola B, Gallois Y, Amouyel P, Ollivier JP, Asmar R.
Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes.
Am J Hypertens 2007;20(1):90-7.

Scuteri A, Volpe M, Asmar R.
Arterial Stiffness and Cognitive Impairment in the Elderly.
High Blood Press Cardiovasc Prev 2007;14(1):33-37.

Asmar R.
Effects of pharmacological intervention on arterial stiffness using pulse wave velocity measurement
J Am Society Hypertens 2007:104-112.

Asmar R.
Is quantification of large artery wall properties relevant for the management of hypertension? Clinical Query.
Renin Angiotensin System in Cardiovascular Medicine 2006;2(3):13-15.

Asmar R, Nisse-Durgeat S.
A large scale study of angiotensin II inhibition therapy in an elderly population: the CHANCE study
Vasc Health Risk Manag 2006;2(3):317-23.

van Popele NM, Mattace-Raso FU, Vliegenthart R, Grobbee DE, Asmar R, van der Kuip DA, Hofman A, de Feijter PJ, Oudkerk M, Witteman JC.
Aortic stiffness is associated with atherosclerosis of the coronary arteries in older adults: the Rotterdam Study.
J Hypertens 2006;24(12):2371-6.

Topouchian JA, El Assaad MA, Orobinskaia LV, El Feghali RN, Asmar RG.
Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT).
Blood Press Monit 2006;11(3):165-71.

Baguet JP, Nisse-Durgeat S, Mouret S, Asmar R, Mallion JM.
A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
Int J Clin Pract 2006;60(4):391-8.

Asmar R
Targeting effective blood pressure control with angiotensin receptor blockers.
Int J Clin Pract 2006;60(3):315-20.

Asmar R
Reply.
Am J Hypertens 2006;19(6):655-656.

Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, Witteman JC
Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study.
Circulation 2006 7;113(5):657-63.

London G, Schmieder R, Calvo C, Asmar R.
Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
Am J Hypertens 2006;19(1):113-21.

Mattace-Raso FU, van der Cammen TJ, van den Elzen AP, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Hofman A, Witteman JC.
Moderate alcohol consumption is associated with reduced arterial stiffness in older adults: the Rotterdam study.
J Gerontol A Biol Sci Med Sci 2005;60(11):1479-83.

Topouchian JA, El Assaad MA, Orobinskaia LV, El Feghali RN, Asmar RG.
Validation of two devices for self-measurement of brachial blood pressure according to the International Protocol of the European Society of Hypertension: the SEINEX SE-9400 and the Microlife BP 3AC1-1.
Blood Press Monit 2005;10(6):325-31.

Bobrie G, Delonca J, Moulin C, Giacomino A, Postel-Vinay N, Asmar R;
A Home Blood Pressure Monitoring Study Comparing the Antihypertensive Efficacy of Two Angiotensin II Receptor Antagonist Fixed Combinations
Am J Hypertens 2005;18(11):1482-8.

Asmar RG.
Cardioprotective effects of anti-hypertensive medications
Curr Med Res Opin 2005;21 Suppl 5:S17-21.

O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P; European Society of Hypertension Working Group on Blood Pressure Monitoring
Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement.
J Hypertens 2005;23(4):697-701.

Parati G, Mendis S, Abegunde D, Asmar R, Mieke S, Murray A, Shengelia B, Steenvoorden G, Van Montfrans G, O'Brien E; World Health Organization.
Recommendations for blood pressure measuring devices for office/clinic use in low resource settings.
Blood Press Monit 2005;10(1):3-10.

Sayegh F, Topouchian J, Hlawaty M, Olzewska M, Asmar R
Regression of left ventricular hypertrophy with moexipril, an angiotensin-converting enzyme inhibitor, in hypertensive patients.
Am J Ther 2005;12(1):3-8.

Asmar R, Porcellati C, Dusing R.
Switch from ABCD pretreatment to A-II-A treatment: a multinational, open, centrally randomized, prospective parallel group comparison
Drugs Exp Clin Res 2004;30(4):153-61.

Bahous SA, Stephan A, Barakat W, Blacher J, Asmar R, Safar ME
Aortic pulse wave velocity in renal transplant patients.
Kidney Int 2004;66(4):1486-92.

Mattace-Raso FU, van der Cammen TJ, van der Meer IM, Schalekamp MA, Asmar R, Hofman A, Witteman JC
C-reactive protein and arterial stiffness in older adults: the Rotterdam Study
Atherosclerosis 2004;176(1):111-6.

Luca N, Asmar RG, London GM, O'Rourke MF, Safar ME; REASON Project Investigators
Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects
J Hypertens 2004;22(8):1623-30.

Marre M, Puig JG, Kokot F, Fernandez M, Jermendy G, Opie L, Moyseev V, Scheen A, Ionescu-Tirgoviste C, Saldanha MH, Halabe A, Williams B, Mion J?nior D, Ruiz M, Hermansen K, Tuomilehto J, Finizola B, Gallois Y, Amouyel P, Ollivier JP, Asmar R
Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study.
J Hypertens 2004;22(8):1613-22.

Lacourcière Y, Béliveau R, Conter HS, Burgess ED, Lepage S, Pesant Y, Spence JD, Asmar R, Carrière S, Plante GE
Canadian Hypertension Society. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
Can J Cardiol 2004;20(8):795-9.


Angiotensin-converting enzyme gene polymorphism and common carotid stiffness. The Rotterdam study
Atherosclerosis 2004;174(1):121-6.

Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME; REASON Project.
Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study
Am J Hypertens 2004;17(3):245-51.

Safar ME, Lajemi M, Rudnichi A, Asmar R, Benetos A
Angiotensin-converting enzyme D/I gene polymorphism and age-related changes in pulse pressure in subjects with hypertension.
Arterioscler Thromb Vasc Biol 2004;24(4):782-6.

London GM, Asmar RG, O'Rourke MF, Safar ME; REASON Project Investigators.
Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol
J Am Coll Cardiol 2004;43(1):92-9.

Asmar R.
Benefits of blood pressure reduction in elderly patients
J Hypertens Suppl 2003;21(6):S25-30.

Asmar R, Safar M, Queneau P
Pulse pressure: an important tool in cardiovascular pharmacology and therapeutics
Drugs 2003;63(10):927-32.

O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P; European Society of Hypertension Working Group on Blood Pressure Monitoring.
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement
J Hypertens 2003;21(5):821-48.

Calvo-Vargas C, Padilla-Rios V, Meza-Flores A, Vazquez-Linares G, Troyo-Sanrom?n R, Cerda AP, Asmar R.
Arterial stiffness and blood pressure self-measurement with loaned equipment.
Am J Hypertens 2003;16(5 Pt 1):375-80.

Marre M, Garcia Puig J, Kokot F, Fernandez M, Jermendy G, Opie L, Moyseev V, Scheen A, Ionescu-Tirgoviste C, Saldanha MH, Halabe A, Williams B, Mion D Jr, Ruiz M, Hermansen K, Tuomilehto J, Finizola B, Pozza G, Chastang C, Ollivier JP, Amouyel P, Asmar R.
Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.
J Hypertens Suppl 2003;21(1):S19-24.

El Assaad MA, Topouchian JA, Asmar RG.
Evaluation of two devices for self-measurement of blood pressure according to the international protocol: the Omron M5-I and the Omron 705IT.
Blood Press Monit 2003;8(3):127-33.

Asmar R, Safar M, Queneau P.
Placebo and new therapeutic perspectives for arteriopathy of the lower limbs
J Mal Vasc 2003;28(3):117-20.

O'BRIEN E, PICKERING T, ASMAR R, MYERS M, PARATI G, STAESSEN J, MENGDEN T, IMAI Y, WAEBER B, PALATINI P, ATKINS N, GERIN W
Working Group on Blood Pressure Monitoring of the European Society of Hypertenson International Protocol for validation of blood pressure measuring devices in adults
Blood Pressure Monitoring 2002

Asmar R, Gosse P, Topouchian J, N'tela G, Dudley A, Shepherd GL
Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension.
J Renin Angiotensin Aldosterone Syst 2002;3(3):176-80.

Benetos A, Waeber B, Izzo J, Mitchell G, Resnick L, Asmar R, Safar M.
Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications.
Am J Hypertens 2002;15(12):1101-8.

Pannier B, Guérin A, London G, Asmar R, Safar M; REASON Study.
Combination of low-dose perindopril/indapamide versus atenolol in the hypertensive patient. Effects on systolic pressure and arterial hemodynamics. REASON Study.
Arch Mal Coeur Vaiss 2002;95 Spec No 6:11-6.

Labaki G, Grès CS, Darné B, Bassous M, Asmar R. Green study:
quality of blood pressure measurement by general practitioners
Arch Mal Coeur Vaiss 2002;95(7-8):713-7.

Chemaly E, London G, Benetos A, Darné B, Asmar R.
Comparison of central pulse pressure estimated from pulse wave propagation velocity and carotid pulse pressure measured by applanation tonometry
Arch Mal Coeur Vaiss 2002;95(7-8):637-40.

Gosse P, Dubourg O, Guéret P, De Simone G, Schmieder R, De Leeuw PW, Degaute JP, Garc?a Puig J, Karpov Y, Magometschnigg D, Matos L, Amouyel P, Asmar R, Le Heuzey JY, Nieminen M, Dahl?f B.
Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design.
J Hum Hypertens 2002;16(9):653-9.

Queneau P, Asmar R, Safar M
Placebo effect on diastolic, systolic and pulsed arterial pressure
Presse Med 2002;31(26):1220-3.

El Assaad MA, Topouchian JA, Darné BM, Asmar RG.
Validation of the Omron HEM-907 device for blood pressure measurement
Blood Press Monit 2002;7(4):237-41.

Safar ME, Myers MG, Leenen F, Asmar R.
Gender influence on the dose-ranging of a low-dose perindopril-indapamide combination in hypertension: effect on systolic and pulse pressure.
J Hypertens 2002;20(8):1653-61.

Asmar R, Pannier B, Vol S, Brisac AM, Tichet J, el Hasnaoui A.
Cardiovascular risk factors in France. Prevalence and association
Arch Mal Coeur Vaiss 2002;95(4):239-45.

Asmar R, Sayegh F, Tracz W, Hlawaty M, Olszowska M, Jourde M, Vincent M, Goujoun B, Maldonado J.
Reversal of left ventricular hypertrophy with the ACE inhibitor moexipril in patients with essential hypertension
Acta Cardiol 2002;57(1):31-2.

Parati G, Asmar R, Stergiou GS.
Self blood pressure monitoring at home by wrist devices: a reliable approach?
J Hypertens 2002;20(4):573-8.

Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S
Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study.
Hypertension 2002;39(1):10-5.

Benetos A, Adamopoulos C, Bureau JM, Temmar M, Labat C, Bean K, Thomas F, Pannier B, Asmar R, Zureik M, Safar M, Guize L.
Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period
Circulation 2002;105(10):1202-7.

Staessen JA, Asmar R, De Buyzere M, Imai Y, Parati G, Shimada K, Stergiou G, Red?n J, Verdecchia P;
Participants of the 2001 Consensus Conference on Ambulatory Blood Pressure Monitoring. Task Force II: blood pressure measurement and cardiovascular outcome
Blood Press Monit 2001;6(6):355-70.

Asmar R.
Effect of antihypertensive agents on arterial stiffness as evaluated by pulse wave velocity: clinical implications
Am J Cardiovasc Drugs 2001;1(5):387-97.

Asmar R, Darne B, el Assaad M, Topouchian J.
Assessment of outcomes other than systolic and diastolic blood pressure: pulse pressure, arterial stiffness and heart rate
Blood Press Monit 2001;6(6):329-33.

Asmar R.
Effect of telmisartan on arterial distensibility and central blood pressure in patients with mild to moderate hypertension and Type 2 diabetes mellitus
J Renin Angiotensin Aldosterone Syst 2001;2 Suppl 2:S8-11.

Asmar RG, London GM, O'Rourke ME, Mallion JM, Romero R, Rahn KH, Trimarco B, Fitzgerald D, Hedner T, Duprez D, De Leeuw PW, Sever P, Battegay E, Hitzenberger G, de Luca N, Pol?nia P, Bénétos A, Chastang C, Ollivier JP, Safar ME;
REASON Project Investigators (pREterax in regression of Arterial Stiffness in a contrOlled double-bliNd Study). Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination
J Hypertens Suppl. 2001;19(4):S15-20.

Asmar R, Mallion JM.
CD-ROMs for blood pressure measurement.
Blood Press Monit 2001;6(4):195-6.

Asmar R, Topouchian J, Darne B.
Self monitoring versus ambulatory blood pressure monitoring.
Arch Mal Coeur Vaiss 2001;94(10):1093-8.

Asmar RG, London GM, O'Rourke ME, Safar ME;
REASON Project Coordinators and Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol.
Hypertension 2001;38(4):922-6.

Asmar R, Vol S, Pannier B, Brisac AM, Tichet J, El Hasnaoui A.
High blood pressure and associated cardiovascular risk factors in France
J Hypertens 2001;19(10):1727-32.

Vaïsse B, Ghobrial H, Vaur L, Poncelet P, Asmar R, Herpin D, Mallion JM.
Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring.
Arch Mal Coeur Vaiss 2001;94(8):907-12.

Démolis P, Antony I, Asmar R, Carette B, Vaïsse B.
REVEIL Trial: Study validity, information and logistics. Preliminary results. Quality measures.
Arch Mal Coeur Vaiss 2001;94(8):901-5.

Antony I, Asmar R, Carette B, Démolis P, Vaïsse B.
The REVEIL study: feasibility study of blood pressure self-monitoring. Preliminary results and patient opinions.
Arch Mal Coeur Vaiss. 2001;94(8):897-900.

Asmar R, Nisse-Durgeat S, el Assaad M, Topouchian J, Amah G, Darné B.
Quality of blood pressure measurement in the management of arterial hypertension. Pilot study.
Arch Mal Coeur Vaiss 2001;94(8):885-8.

Asmar R, Safar M, Queneau P
Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension
Am J Hypertens 2001;14(6 Pt 1):546-52.

Asmar R, Vol S, Brisac AM, Tichet J, Topouchian J.
Reference values for clinic pulse pressure in a nonselected population
Am J Hypertens 2001;14(5 Pt 1):415-8.

Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A
Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients.
Hypertension 2001;37(5):1236-41.

Himmelmann A, Kein?nen-Kiukaanniemi S, Wester A, Red?n J, Asmar R, Hedner T;
Effect Study Group. The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension
Blood Press 2001;10(1):43-51.

Asmar R, Topouchian J, Pannier B, Benetos A, Safar M; Scientific, Quality Control, Coordination and Investigation Committees of the Complior Study.
Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study. Scientific, Quality Control, Coordination and Investigation Committees of the Complior Study.
J Hypertens. 2001;19(4):813-8.

Smulyan H, Asmar RG, Rudnicki A, London GM, Safar ME.
Comparative effects of aging in men and women on the properties of the arterial tree
J Am Coll Cardiol 2001;37(5):1374-80.

Lajemi M, Labat C, Gautier S, Lacolley P, Safar M, Asmar R, Cambien F, Benetos A.
Angiotensin II type 1 receptor-153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects
J Hypertens 2001;19(3):407-13.

Asmar R, Rudnichi A, Blacher J, London GM, Safar ME.
Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations.
Am J Hypertens. 2001;14(2):91-7.

van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, Hoeks AP, van der Kuip DA, Hofman A, Witteman JC
Association between arterial stiffness and atherosclerosis: the Rotterdam Study
Stroke 2001;32(2):454-60.

Blacher J, Fournier V, Asmar R, Guerin AP, Pannier B, Safar ME, London GM
Aortic Pulse Wave Velocity as a Marker of Atherosclerosis in Hypertension.
CVR & R 2001; 431: 420-42.

1991 - 2000
1980 - 1990








SiteMap  Contact
© 2011 All rights reserved - Prof. Asmar
Developed by Linda Mahmoudi /E-mail: Lindamahmoudi@hotmail.com